Currently, there are 467.21M common shares owned by the public and among those 411.62M shares have been available to trade.
The company’s stock has a 5-day price change of -7.18% and 0.77% over the past three months. PATH shares are trading -47.46% year to date (YTD), with the 12-month market performance down to -48.32% lower. It has a 12-month low price of $10.37 and touched a high of $27.87 over the same period. PATH has an average intraday trading volume of 8.32 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -8.11%, -2.61%, and -12.42% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of UiPath Inc (NYSE: PATH) shares accounts for 49.09% of the company’s 467.21M shares outstanding.
It has a market capitalization of $7.46B and a beta (3y monthly) value of 0.94. The earnings-per-share (ttm) stands at -$0.16. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.84% over the week and 5.00% over the month.
Earnings per share for the fiscal year are expected to decrease by -11.33%, and 7.68% over the next financial year. EPS should grow at an annualized rate of 32.50% over the next five years, compared to 20.57% over the past 5-year period.
Macquarie coverage for the UiPath Inc (PATH) stock in a research note released on June 03, 2024 offered a Neutral rating with a price target of $12. William Blair was of a view on May 30, 2024 that the stock is Mkt Perform, while Truist gave the stock Hold rating on May 30, 2024, issuing a price target of $32- $14. TD Cowen on their part issued Hold rating on May 30, 2024.
